MEDICINOVA

medicinova-logo

MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive co... mmercial potential and patent assets having claims of commercially adequate scope. MediciNova’s pipeline includes clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers

#People #Financial #Website #More

MEDICINOVA

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2000-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.medicinova.com

Total Employee:
11+

Status:
Active

Contact:
(858) 373-1500

Email Addresses:
[email protected]

Total Funding:
92 M USD

Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins Nginx



Current Advisors List

not_available_image

Yutaka Kobayashi Director @ MediciNova
Board_member

not_available_image

Yoshio Ishizaka Board of Director @ MediciNova
Board_member

Current Employees Featured

not_available_image

Masatsune Okajima
Masatsune Okajima Representative and Vice President of Tokyo Office @ MediciNova
Representative and Vice President of Tokyo Office

jeff-himawan_image

Jeff Himawan
Jeff Himawan Executive Chairman @ MediciNova
Executive Chairman

yuichi-iwaki_image

Yuichi Iwaki
Yuichi Iwaki Founder , President and Chief Executive Officer @ MediciNova
Founder , President and Chief Executive Officer

geoffrey-obrien_image

Geoffrey O’Brien
Geoffrey O’Brien Management Division, Vice President @ MediciNova
Management Division, Vice President
2009-06-01

carla-reyes_image

Carla Reyes
Carla Reyes Chief Financial Officer @ MediciNova
Chief Financial Officer

kazuko-matsuda_image

Kazuko Matsuda
Kazuko Matsuda CMO @ MediciNova
CMO

Founder


yuichi-iwaki_image

Yuichi Iwaki

Stock Details


Company's stock symbol is NASDAQ:MNOV

Investors List

3d-investment-partners_image

3D Investment Partners

3D Investment Partners investment in Post-IPO Equity - MediciNova

aspire-capital-fund_image

Aspire Capital Partners LLC

Aspire Capital Partners LLC investment in Post-IPO Equity - MediciNova

dream-incubator_image

Dream Incubator

Dream Incubator investment in Venture Round - MediciNova

Official Site Inspections

http://www.medicinova.com Semrush global rank: 4.73 M Semrush visits lastest month: 1.99 K

  • Host name: 254.220.178.68.host.secureserver.net
  • IP address: 68.178.220.254
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "MediciNova"

Home - MediciNova, Inc.

MediciNova is a biopharmaceutical company that is developing novel therapeutics with a primary focus on neurology, respiratory, and liver diseases with unmet medical needs.See details»

Company - MediciNova, Inc.

MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet …See details»

Corporate Profile | MediciNova, Inc.

MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet …See details»

Investor Home - MediciNova, Inc.

6 days ago · MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with …See details»

MediciNova - Crunchbase Company Profile & Funding

MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market.See details»

Corporate Presentation - MediciNova

Mar 12, 2021 · MediciNova, Inc. is a publicly-traded, development-stage biopharmaceutical company focused on developing novel therapeutics for the treatment of diseases with high …See details»

MediciNova,Inc - VentureRadar

MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a …See details»

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter …

Nov 19, 2024 · MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic, and …See details»

MediciNova, Inc. (MNOV) Company Profile & Overview - Stock …

Feb 8, 2005 · MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in …See details»

MediciNova History - MediciNova, Inc.

MediciNova was established in San Diego as a biopharmaceutical company focused on acquiring and accelerating the global development and commercialization of innovative pharmaceutical …See details»

MediciNova, Inc. Company Profile | La Jolla, CA | Competitors ...

Find company research, competitor information, contact details & financial data for MediciNova, Inc. of La Jolla, CA. Get the latest business insights from Dun & Bradstreet.See details»

MediciNova Reaches Agreement to Participate in Grant-Funded …

Aug 16, 2022 · MediciNova has reached an agreement to collaborate with the University Health Network, an academic health sciences center located in Toronto, which has the largest …See details»

MediciNova, Inc. (MNOV) - Yahoo Finance

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.See details»

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter …

Nov 19, 2024 · Since its founding, MediciNova has been clear in its mission to deliver new treatment options to the patients suffering with unmet medical needs.See details»

MediciNova Company Profile - Office Locations, Competitors

MediciNova, Inc. is a biopharmaceutical company founded upon acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a commercial …See details»

Board of Directors - MediciNova, Inc.

Dr. Matsuda has served as Chief Medical Officer and previously as Vice President of Clinical Development for MediciNova since 2010 and is responsible for all clinical development. …See details»

EW Healthcare Partners - Portfolio - MediciNova, Inc.

MediciNova, Inc. Focuses on acquiring and developing novel, small-molecule therapeutics for the US marketSee details»

MediciNova Receives Gene Therapy Milestone Payments

Apr 22, 2021 · MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet …See details»

MediciNova, Inc. (MNOV) Stock Price, Quote & News - Stock …

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.See details»

Development Pipeline - MediciNova, Inc.

MediciNova History; Careers. Current Openings; Clinical Development. Development Pipeline; Core Programs. MN-001 (Fibrotic Diseases) MN-166 (Neurology Diseases) MN-221 …See details»

linkstock.net © 2022. All rights reserved